1189644-16-3

Usage

Uses

Used in Pharmaceutical Research:
BMY 28674-d8 is used as a labeled metabolite in pharmaceutical research for studying the metabolism and pharmacokinetics of Buspirone. Its radioactive labeling allows researchers to track its distribution, metabolism, and excretion in the body, providing valuable insights into the drug's behavior and potential side effects.
Used in Drug Development:
BMY 28674-d8 is also used in drug development as a reference compound for the synthesis and characterization of new Buspirone analogs. Its labeled nature allows for the easy detection and quantification of these analogs, facilitating the optimization of their chemical structures and therapeutic properties.
Used in Analytical Chemistry:
In analytical chemistry, BMY 28674-d8 is used as a reference material for the development and validation of analytical methods for the detection and quantification of Buspirone and its metabolites. Its labeled nature provides a sensitive and specific means of detecting the presence of these compounds in biological samples, such as blood, urine, or tissue extracts.
Used in Radiopharmaceutical Development:
BMY 28674-d8 can also be used in the development of radiopharmaceuticals for imaging studies. Its radioactive labeling allows for the visualization of Buspirone's distribution and metabolism in the body, providing valuable information on its pharmacological effects and potential therapeutic applications.
Overall, BMY 28674-d8 is a versatile compound with a range of applications in pharmaceutical research, drug development, analytical chemistry, and radiopharmaceutical development. Its unique properties make it a valuable tool for studying the behavior of Buspirone and its analogs, as well as for developing new methods for their detection and quantification.